• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Coordinates

Institution

The Montreal Children's Hospital

City

Montreal

Contact This Member

Patricia Fontela

Dr. Fontela is an Assistant Professor in the Department of Pediatrics, at McGill University, and a staff physician within the Division of Pediatric Critical Care Medicine at the Montreal Children’s Hospital.

Dr. Patricia Fontela obtained her medical degree in Brazil (FFFCMPA) in 1997. After concluding her medical training in Pediatrics and Pediatric Critical Care, she pursued a M.Sc. in Medicine in the same country. After moving to Canada in 2004, she completed a second fellowship in Pediatric Critical Care (2004-2007), as well as her Ph.D. in Epidemiology at McGill University (2007-2011). In 2012, she was hired as an Assistant Professor in the Department of Pediatrics, at McGill University, and as staff physician within the Division of Pediatric Critical Care Medicine at the Montreal Children’s Hospital. Her research focuses on infection control in the pediatric critical care setting. Currently, she studies the use of antibiotics in pediatric critical care units, including the determinants that influence antibiotic usage, the clinical reasoning behind antibiotic-related decisions, and the use of biomarkers to guide antibiotic treatments in this setting.